González-Manjarrez NV, Arteaga-Ortiz R, Ortiz-Olaya NY

Language: Spanish
References: 16
Page: 49-54
PDF size: 289.95 Kb.

ABSTRACT

Objectives: To analyze the knowledge that people with breast cancer have about the use of turmeric as a coadjuvant treatment. Material and methods: The study was carried out through a semi-structured interview, qualitative in which the knowledge of 20% of the population of people with breast cancer who attended the Hospital Civil Fray Antonio Alcalde in the outpatient clinic was evaluated. Oncology area, on functional foods and the use of turmeric as a coadjuvant treatment to their oncological treatment. Results: Of a total of 20 people interviewed with breast cancer, only 8 people reported knowing what a functional food was and 7 of them had consumed it, while 13 people of the total sample (n = 20) reported having heard about the turmeric, and the rest (n = 7) do not know what it is. However, only two people who have heard about it know about the anti-carcinogenic effects of turmeric as a coadjuvant treatment. Conclusion: According to the research carried out, it is concluded that the scientific basis in clinical trials on the effect of turmeric in the adjuvant treatment of breast cancer is scarce and is probably the reason why health experts do not recommend it and the population He is still unaware of the effects that functional foods, especially turmeric, can provide for his health.

REFERENCES

1. Rodríguez, A. S. Cáncer de mama. Cirugía y Cirujanos. Redalyc. org. 2005; 73(006) 423-424. Recuperado de: http://www.redalyc. org/pdf/662/66273601.pdf

2. Alvarado-Cabrero, I. Conceptos actuales en el cáncer mamario. Cirugía y Cirujanos [Internet]. 2015;83(1):1- 2. Recuperado de: http://www.redalyc.org/articulo. oa?Id=66242703001

3. Brito, S., Germán, P., Braojos, I. Cirugía conservadora en el cáncer de mama. Revista Cubana de Cirugía, Sociedad Cubana de Cirugía La Habana, Cuba. Redalyc.org. 2012; 53(2) 201-212. Recuperado de: http://www.redalyc.org/articulo.oa?Id=281237144011

4. Herrera-González, NE, Martínez-García, F, Mejía-Jiménez, E. El efecto Warburg: la mano derecha en el desarrollo del cáncer. Revista de Especialidades Médico-Quirúrgicas [Internet]. 2015;20(2):171-177. Recuperado de: http://www.redalyc.org/ articulo.oa?Id=47345917008

5. Knaul, F. Una mujer ante el cáncer de mama en México. Salud Pública de México.redalyc.org. 2009; 51 (2. S364-s371. Recuperado de: http://www.redalyc.org/articulo.oa?Id=10616164030

6. Felicia, k., nigenda, g., lozano, r., arreola, r. Y cols. Cáncer de mama en méxico: una prioridad apremiante. Salud publica mex 2009;51 supl 2:s335-s344. Recuperado de: fi le:///c:/users/natalia/ documents/semestres/6to%20semestre/comunicación%20 cientifica%20en%20nutrición/art%20cá ncer%20de%20mama. pdf

7. Hernández Moreno, FP, Landero Hernández, R. Aspectos Psicosociales Relacionados con el TEPT en Pacientes con Cáncer de Mama. Acta de Investigación Psicológica - Psychological Research Records [Internet]. 2015;5(1):1881-1891. Recuperado de: http://www.redalyc.org/articulo.oa?Id=358941542007

8. Farjas A Pilar. Sobre los alimentos funcionales: salud pública. Rev. Esp (internet). 2003 (citado 2017 Feb 05); 77(3): 335- 527. Disponible en: http://dx.doi.org/10.1590/S1135- 57272003000300002

9. Olagnero Gabriela, et al. Fuctional foods: estudio sobre alimentos funcionales. Rev. Diaeta Buenos Aires (internet). 2007 (citado 2017 Feb 05); 25(121): 20-33. Disponible en: http://andeguat.org. gt/wp-content/uploads/2015/03/Alimentos-funcionales-fibraprebi% C3%b3ticos-probi%C3%b3ticos-y-simbi%C3%b3ticos1. pdf

10. Bengmark, M Dolores, et al. Efectos saludables de la cúrcuma y de los curcuminoides. Stig Institute of Hepatology University College London Medical School. (internet) 2009(citado 2017 Feb 13); 45(57) 69-75. Disponible en: https://uvadoc.uva.es/ bitstream/10324/7305/1/TFM-M163.pdf

11. Díaz JL. Curcuma longa y su pontencial molecular benefi cioso sobre los procesos infl amatorios, cáncer y enfermedades crónico degenerativas. Revista in crescendo - ciencias de la salud. (internet) 2014 (citado 2017 feb 05); 01(01):115 – 12.

12. Peralta-Rodríguez, R, Valdivia, A, Mendoza, M, Rodríguez, J, Marrero, D, Paniagua, L, Romero, P, Taniguchi, K, Salcedo, M. Los genes del cáncer. Revista Médica del Instituto Mexicano del Seguro Social [Internet]. 2015;53(2):S178-S187. Recuperado de: http://www.redalyc.org/articulo.oa?Id=457744942010

13. Sharmila S, Rakesh KS. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa. Highwire. Feb 2011; 28(6):1277–1286

14. Baatout S, Derradji H, Jacquet P, Ooms D, Michaux A, Mergeay M. Eff ect of curcuma on radiation-induced apoptosis in human cancer cells. Portal Regional de la BVS. 24(2): 321-9, 2011 Feb.

15. La curcumina inhibe la proliferación y migración aumentando el Bax en relación con Bcl-2 y disminuyendo la expresión de NF-κ κbp65 en las células MDA-MB-231 el cáncer de mama.

16. Tian, Binqiang. Wang, Zhiping and cols. Eff ects of curcumin on bladder cáncer cells and development of urothelial tumors in a rat bladder carcinogénesis model. Cancer lett; 264(2)2014 recuperado 6 de oct 016 disponible en: http://pesquisa.bvsalud. org/portal/resource/es/mdl-18342436